Cumulative Radiation Exposure in Covid-19 Patients Admitted to the Intensive Care Unit.


Journal

Radiation research
ISSN: 1938-5404
Titre abrégé: Radiat Res
Pays: United States
ID NLM: 0401245

Informations de publication

Date de publication:
01 06 2022
Historique:
received: 20 10 2021
accepted: 11 02 2022
pubmed: 8 3 2022
medline: 7 6 2022
entrez: 7 3 2022
Statut: ppublish

Résumé

Medical imaging plays a major role in coronavirus disease-2019 (COVID-19) patient diagnosis and management. However, the radiation dose received from medical procedures by these patients has been poorly investigated. We aimed to estimate the cumulative effective dose (CED) related to medical exposure in COVID-19 patients admitted to the intensive care unit (ICU) in comparison to the usual critically ill patients. We designed a descriptive cohort study including 90 successive ICU COVID-19 patients admitted between March and May 2020 and 90 successive non-COVID-19 patients admitted between March and May 2019. In this study, the CED resulting from all radiological examinations was calculated and clinical characteristics predictive of higher exposure risk identified. The number of radiological examinations was 12.0 (5.0-26.0) [median (interquartile range) in COVID-19 vs. 4.0 (2.0-8.0) in non-COVID-19 patient (P < 0.001)]. The CED during a four-month period was 4.2 mSv (1.9-11.2) in the COVID-19 vs. 1.2 mSv (0.13-6.19) in the non-COVID-19 patients (P < 0.001). In the survivors, the CED in COVID-19 vs. non-COVID-19 patients was ≥100 mSv in 3% vs. 0%, 10-100 mSv in 23% vs. 15%, 1-10 mSv in 56% vs. 30% and <1 mSv in 18% vs. 55%. The CED (P < 0.001) and CED per ICU hospitalization day (P = 0.004) were significantly higher in COVID-19 than non-COVID-19 patients. The CED correlated significantly with the hospitalization duration (r = 0.45, P < 0.001) and the number of conventional radiological examinations (r = 0.8, P < 0.001). To conclude, more radiological examinations were performed in critically ill COVID-19 patients than non-COVID-19 patients resulting in higher CED. In COVID-19 patients, contribution of strategies to limit CED should be investigated in the future.

Identifiants

pubmed: 35254427
pii: 478744
doi: 10.1667/RADE-21-00203.1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

605-612

Informations de copyright

©2022 by Radiation Research Society. All rights of reproduction in any form reserved.

Auteurs

Lama Hadid-Beurrier (L)

Department of Medical Physics and Radiation Protection, Lariboisière Hospital, APHP, Paris, France.
Department of Skeletal and Visceral Radiology, Lariboisière Hospital, APHP, Paris University, Paris, France.

Axel Cohen (A)

Department of Skeletal and Visceral Radiology, Lariboisière Hospital, APHP, Paris University, Paris, France.

Bouchra Habib-Geryes (B)

Department of Medical Physics, Necker-Enfants-Malades Hospital, APHP, Paris, France.

Sébastian Voicu (S)

Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Federation of Toxicology, APHP, INSERM UMRS-1144, Paris University, Paris, France.

Isabelle Malissin (I)

Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Federation of Toxicology, APHP, INSERM UMRS-1144, Paris University, Paris, France.

Nicolas Deye (N)

Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Federation of Toxicology, APHP, INSERM UMRS-1144, Paris University, Paris, France.

Bruno Mégarbane (B)

Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Federation of Toxicology, APHP, INSERM UMRS-1144, Paris University, Paris, France.

Valérie Bousson (V)

Department of Skeletal and Visceral Radiology, Lariboisière Hospital, APHP, Paris University, Paris, France.
Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7052, Université de Paris, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH